Desulfovibrio (DSV) are sulfate-reducing bacteria (SRB) that are ubiquitously present in the
environment and as resident commensal bacteria within the human gastrointestinal tract …

At present, a large number of relevant studies have suggested that the changes in gut
microbiota are related to the course of nervous system diseases, and the microbiota-gut …

Glaucoma is a common irreversible vision loss disorder because of the gradual loss of
retinal ganglion cells (RGCs) and the optic nerve axons. Major risk factors include elder age …

Numerous studies have described the notable impact of gut microbiota on the brain in
Alzheimer's disease (AD) via the gut–brain axis. However, the molecular mechanisms …

The accumulation of amyloid-beta plaques in the brain is a central pathological feature of
Alzheimer's disease. It is believed that amyloid responses may be a result of the host …

Over the past decades, significant efforts have been made to understand the precise
mechanisms underlying the pathogenesis of Alzheimer's disease (AD), the most common …

Novel Haloacethydrazides as AEP Inhibitors for Treating Alzheimer’s Disease Page 1 Novel
Haloacethydrazides as AEP Inhibitors for Treating Alzheimer’s Disease Ram W. Sabnis* and …

Over the past decade, microbiome research has significantly expanded in both scope and
volume, leading to the development of new models and treatments targeting the gut–brain …

3-Alkynyl Carboxamides as AEP Modulators for Treating Alzheimer’s Disease Page 1 3‑Alkynyl
Carboxamides as AEP Modulators for Treating Alzheimer’s Disease Ram W. Sabnis* and Anika …

Salivary microbiome alterations associated with cognitive function have been reported in
patients with neurodegenerative diseases. Gut microorganisms can modulate therapeutic …